CABA vs. OLMA

In the year-to-date period, CABA achieves a -89.91% return, which is significantly lower than OLMA's -56.17% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Cabaletta Bio, Inc. (CABA) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CABA Sharpe Ratio is -0.87, which is comparable to the OLMA Sharpe Ratio of -0.75. The chart below compares the historical Sharpe Ratios of CABA and OLMA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CABA nor OLMA has paid dividends to shareholders.

The maximum CABA drawdown since its inception was -96.63%, roughly equal to the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for CABA and OLMA. For additional features, visit the drawdowns tool.

Cabaletta Bio, Inc. (CABA) has a higher volatility of 46.29% compared to Olema Pharmaceuticals, Inc. (OLMA) at 29.71%. This indicates that CABA's price experiences larger fluctuations and is considered to be riskier than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Cabaletta Bio, Inc. and Olema Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.